Upgrade to SI Premium - Free Trial

Jefferies Upgrades Abbott Labs (ABT) to Buy

July 18, 2025 2:07 AM
Jefferies analyst Matthew Taylor upgraded Abbott Labs (NYSE: ABT) from Hold to Buy with a price target of $145.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Upgrades

Next Articles